{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T14:10:56Z","timestamp":1790863856887,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2004,6,1]],"date-time":"2004-06-01T00:00:00Z","timestamp":1086048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2004,6]]},"DOI":"10.1016\/j.intimp.2004.02.011","type":"journal-article","created":{"date-parts":[[2004,3,23]],"date-time":"2004-03-23T18:29:08Z","timestamp":1080066548000},"page":"745-753","source":"Crossref","is-referenced-by-count":125,"title":["Immunoglobulin therapy to control lung damage in patients with common variable immunodeficiency"],"prefix":"10.1016","volume":"4","author":[{"given":"Javier","family":"de Gracia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montserrat","family":"Vendrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"\u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Pallisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Jos\u00e9","family":"Rodrigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"de la Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Mata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Andreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferran","family":"Morell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2004.02.011_BIB1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2249.2003.02110.x","article-title":"Primary immunodeficiency diseases: an update","volume":"132","author":"Chapel","year":"2003","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.intimp.2004.02.011_BIB2","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1067\/mai.2002.124999","article-title":"Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency","volume":"109","author":"Busse","year":"2002","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2004.02.011_BIB3","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1056\/NEJM199107113250207","article-title":"The use of intravenous immune globulin in immunodeficiency diseases","volume":"325","author":"Buckley","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2004.02.011_BIB4","first-page":"201","article-title":"Utilizaci\u00f3n de gammaglobulina humana en el tratamiento de la inmunodeficiencia com\u00fan variable","volume":"104","author":"De Gracia","year":"1995","journal-title":"Med. Clin. (Barc.)"},{"issue":"3A","key":"10.1016\/j.intimp.2004.02.011_BIB5","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/0002-9343(84)90320-6","article-title":"Intravenous immune globulin therapy in hypogammaglobulinaemia. A Review","volume":"76","author":"Pirofsky","year":"1984","journal-title":"Am. J. Med."},{"key":"10.1016\/j.intimp.2004.02.011_BIB6","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF01486738","article-title":"Relationship of dose of intravenous gammaglobulin to the prevention of infections in adults with common variable immunodeficiency","volume":"20","author":"Pruzanski","year":"1996","journal-title":"Inflammation"},{"issue":"3A","key":"10.1016\/j.intimp.2004.02.011_BIB7","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0002-9343(84)90324-3","article-title":"Comparison of high-dose and low-dose intravenous immunoglobulin therapy in patients with primary immunodeficiency disease","volume":"76","author":"Ochs","year":"1984","journal-title":"Am. J. Med."},{"key":"10.1016\/j.intimp.2004.02.011_BIB8","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0090-1229(87)90123-1","article-title":"Results of a prospective controlled two-dose crossover study with intravenous immunoglobulin and comparison with plasma treatment","volume":"43","author":"Bernatowska","year":"1987","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.intimp.2004.02.011_BIB9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7326\/0003-4819-135-3-200108070-00008","article-title":"The effect of two different dosages of intravenous immunoglobulin on the incidence of recurrent infections in patients with primary hypogammaglobulinemia. A randomised, double-blind, multicenter crossover trial","volume":"135","author":"Eijkhout","year":"2001","journal-title":"Ann. Intern. Med."},{"issue":"8541","key":"10.1016\/j.intimp.2004.02.011_BIB10","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(87)90494-6","article-title":"High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease","volume":"1","author":"Roifman","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.intimp.2004.02.011_BIB11","first-page":"159","article-title":"Availability of immune globulin intravenous for treatment of immune deficient patients\u2014United States, 1997\u20131998","volume":"48","year":"1999","journal-title":"MMWR"},{"key":"10.1016\/j.intimp.2004.02.011_BIB12","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/S0091-6749(99)70085-0","article-title":"Pulmonary abnormalities in patients with primary hypogammaglobulinemia","volume":"104","author":"Kainulainen","year":"1999","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2004.02.011_BIB13","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1007\/s002470050235","article-title":"Clinical utility of high-resolution pulmonary computed tomography in children with antibody deficiency disorders","volume":"27","author":"Manson","year":"1997","journal-title":"Pediatr. Radiol."},{"key":"10.1016\/j.intimp.2004.02.011_BIB14","unstructured":"EMEA. Core SPC for human normal immunoglobulin for intravenous administration (IVIg). CPMP\/BPWG\/859\/95 rev.1, 2000."},{"key":"10.1016\/j.intimp.2004.02.011_BIB15","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1164\/ajrccm.162.4.9910088","article-title":"Utility of the antibody response to conjugated Haemophilus influenzae Type B vaccine for diagnosis of primary humoral immunodeficiency","volume":"162","author":"Rodrigo","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.intimp.2004.02.011_BIB16","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1128\/CDLI.4.2.168-172.1997","article-title":"Characterization of specific IgG and its subclases (IgG1 and IgG2) against the 23-valent pneumococcal vaccine in a healthy adult population. Proposal of a response criteria","volume":"4","author":"Rodrigo","year":"1997","journal-title":"Clin. Diagn. Lab. Immunol."},{"issue":"Suppl. 1","key":"10.1016\/j.intimp.2004.02.011_BIB17","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1093\/clind\/15.Supplement_1.S5","article-title":"General guidelines for the clinical evaluation of anti-infective drug products. Infectious Diseases Society of America and the Food and Drug Administration","volume":"15","author":"Beam","year":"1992","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.intimp.2004.02.011_BIB18","first-page":"217","article-title":"Spirometric references values from a Mediterranean population","volume":"22","author":"Roca","year":"1986","journal-title":"Bull. Eur. Physiopathol. Respir."},{"key":"10.1016\/j.intimp.2004.02.011_BIB19","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/00004728-198206000-00001","article-title":"Computed tomography of bronchiectasis","volume":"6","author":"Naidich","year":"1982","journal-title":"J. Comput. Assist. Tomogr."},{"key":"10.1016\/j.intimp.2004.02.011_BIB20","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/thx.5.3.233","article-title":"Reduction in bronchial subdivision in bronchiectasis","volume":"5","author":"Reid","year":"1950","journal-title":"Thorax"},{"key":"10.1016\/j.intimp.2004.02.011_BIB21","first-page":"166","article-title":"Valores normales de las subclases de la IgG en una poblaci\u00f3n de adultos. Su importancia en el estudio de los d\u00e9ficits de las mismas","volume":"98","author":"Rodrigo","year":"1992","journal-title":"Med. Clin. (Barc.)"},{"key":"10.1016\/j.intimp.2004.02.011_BIB22","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1056\/NEJMra012519","article-title":"Bronchiectasis","volume":"346","author":"Barker","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.intimp.2004.02.011_BIB23","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1136\/thorax.55.11.970","article-title":"Factors influencing airway inflammation in chronic obstructive pulmonary disease","volume":"55","author":"Hill","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/j.intimp.2004.02.011_BIB24","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0033-8389(05)70009-9","article-title":"Bronchiectasis","volume":"36","author":"Hansell","year":"1998","journal-title":"Radiol. Clin. North Am."},{"key":"10.1016\/j.intimp.2004.02.011_BIB25","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1378\/chest.103.5.1482","article-title":"The bronchitis index. A semiquantitative visual scale for the assessment of airways inflammation","volume":"103","author":"Thompson","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.intimp.2004.02.011_BIB26","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1164\/ajrccm.158.3.9710031","article-title":"Elevated levels of expired breath hydrogen peroxide in bronchiectasis","volume":"158","author":"Loukides","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.intimp.2004.02.011_BIB27","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0954-6111(06)80006-5","article-title":"Radiological evidence of progression of bronchiectasis","volume":"86","author":"Munro","year":"1992","journal-title":"Respir. Med."},{"key":"10.1016\/j.intimp.2004.02.011_BIB28","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/qjmed\/95.10.655","article-title":"Common variable immune deficiency: respiratory, pulmonary function and high-resolution scan findings","volume":"95","author":"Thickett","year":"2002","journal-title":"QJM"},{"key":"10.1016\/j.intimp.2004.02.011_BIB29","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1164\/ajrccm.162.2.9910086","article-title":"Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis","volume":"162","author":"Barker","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.intimp.2004.02.011_BIB30","first-page":"156","article-title":"Anti-inflammatory activity of macrolide antibiotics","volume":"292","author":"Ianaro","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.intimp.2004.02.011_BIB31","article-title":"Inhaled steroids for bronchiectasis","volume":"2","author":"Kolbe","year":"2000","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.intimp.2004.02.011_BIB32","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1183\/09031936.95.08091479","article-title":"In vivo study of indomethacin in bronchiectasis: effect on neutrophil function and lung secretion","volume":"8","author":"Llewellyn-Jones","year":"1995","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.intimp.2004.02.011_BIB33","article-title":"Inhaled hyperosmolar agents for bronchiectasis (Cochrane Review)","volume":"2","author":"Wills","year":"2001","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.intimp.2004.02.011_BIB34","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0022-3476(99)70246-5","article-title":"Early and prolonged intravenous immunoglobulin replacement therapy in childhood agammaglobulinaemia: a retrospective survey of 31 patients","volume":"134","author":"Quartier","year":"1999","journal-title":"J. Pediatr."},{"key":"10.1016\/j.intimp.2004.02.011_BIB35","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1067\/mai.2002.122466","article-title":"Primary immunodeficiency disorders: antibody deficiency","volume":"109","author":"Ballow","year":"2002","journal-title":"J. Allergy Clin. Immunol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576904000773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576904000773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T05:13:03Z","timestamp":1682658783000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576904000773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,6]]}},"alternative-id":["S1567576904000773"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2004.02.011","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2004,6]]}}}